BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37870230)

  • 1. Clinical Utility of Melanoma Sentinel Lymph Node Biopsy Nomograms.
    Drebin HM; Hosein S; Kurtansky NR; Nadelmann E; Moy AP; Ariyan CE; Bello DM; Brady MS; Coit DG; Marchetti MA; Bartlett EK
    J Am Coll Surg; 2024 Jan; 238(1):23-31. PubMed ID: 37870230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.
    Olofsson Bagge R; Mikiver R; Marchetti MA; Lo SN; van Akkooi ACJ; Coit DG; Ingvar C; Isaksson K; Scolyer RA; Thompson JF; Varey AHR; Wong SL; Lyth J; Bartlett EK
    JAMA Surg; 2024 Mar; 159(3):260-268. PubMed ID: 38198163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are the MIA and MSKCC nomograms useful in selecting patients with melanoma for sentinel lymph node biopsy?
    Hosein S; Drebin HM; Kurtansky NR; Olofsson Bagge R; Coit DG; Bartlett EK; Marchetti MA
    J Surg Oncol; 2023 Jun; 127(7):1167-1173. PubMed ID: 36905337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Melanoma Institute of Australia's Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma.
    Maddineni S; Dizon MP; Muralidharan V; Young LA; Sunwoo JB; Baik FM; Swetter SM
    Ann Surg Oncol; 2024 Apr; 31(4):2737-2746. PubMed ID: 38216800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of a Model for Predicting the Risk of Sentinel Lymph Node Metastasis in Patients With Cutaneous Melanoma.
    Marchetti MA; Dusza SW; Bartlett EK
    JAMA Dermatol; 2022 Jun; 158(6):680-683. PubMed ID: 35475908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma.
    Miller JR; Lo SN; Nosrati M; Stretch JR; Spillane AJ; Saw RPM; Shannon KF; Nieweg OE; Ch'ng S; Kim KB; Leong SP; Thompson JF; Scolyer RA; Kashani-Sabet M
    JAMA Netw Open; 2023 Apr; 6(4):e236356. PubMed ID: 37074717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
    Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
    Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram to identify high-risk melanoma patients with a negative sentinel lymph node biopsy.
    Bertolli E; de Macedo MP; Calsavara VF; Pinto CAL; Duprat Neto JP
    J Am Acad Dermatol; 2019 Mar; 80(3):722-726. PubMed ID: 30395920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
    Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
    J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of two different validated models to predict axillary non-sentinel lymph node status by sentinel node biopsy in a single Italian center.
    Bertozzi S; Londero AP; Giacomuzzi F; Angione V; Carbone A; Petri R; Bernardi S
    Breast Cancer; 2015 Jul; 22(4):350-5. PubMed ID: 23832256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a nomogram to predict the presence of sentinel lymph node metastases in melanoma.
    Piñero A; Canteras M; Ortiz E; Martínez-Barba E; Parrilla P
    Ann Surg Oncol; 2008 Oct; 15(10):2874-7. PubMed ID: 18648880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax.
    Wagner JD; Park HM; Coleman JJ; Love C; Hayes JT
    Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):313-21. PubMed ID: 10722003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
    Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Lymph Node Ultrasound Prior to Sentinel Lymph Node Biopsy in 384 Patients with Melanoma: A Cost-Effectiveness Analysis.
    Olmedo D; Brotons-Seguí M; Del Toro C; González M; Requena C; Traves V; Pla A; Bolumar I; Moreno-Ramírez D; Nagore E
    Actas Dermosifiliogr; 2017 Dec; 108(10):931-938. PubMed ID: 28801012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinical Decision Tool to Calculate Pretest Probability of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.
    Tripathi R; Larson K; Fowler G; Han D; Vetto JT; Bordeaux JS; Yu WY
    Ann Surg Oncol; 2023 Jul; 30(7):4321-4328. PubMed ID: 36840860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can a machine-learning model improve the prediction of nodal stage after a positive sentinel lymph node biopsy in breast cancer?
    Madekivi V; Boström P; Karlsson A; Aaltonen R; Salminen E
    Acta Oncol; 2020 Jun; 59(6):689-695. PubMed ID: 32148141
    [No Abstract]   [Full Text] [Related]  

  • 18. Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.
    Woods JF; De Marchi JA; Lowery AJ; Hill AD
    Ir J Med Sci; 2015 Dec; 184(4):769-73. PubMed ID: 24997756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes.
    Li AT; Law J; Ch'ng S; Scolyer RA; Thompson JF; Lo SN; Varey AHR
    Eur J Cancer; 2023 Aug; 189():112901. PubMed ID: 37263897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.
    Beasley GM; Hu Y; Youngwirth L; Scheri RP; Salama AK; Rossfeld K; Gardezi S; Agnese DM; Howard JH; Tyler DS; Slingluff CL; Terando AM
    Ann Surg Oncol; 2017 Sep; 24(9):2728-2733. PubMed ID: 28508145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.